Ixazomib Adverse Event Report 2018


This report includes data from the FDA’s Adverse Events Reports for 2018.  We removed reports where the subject of the report was taking only this drug. This report provides the following fields:

  • ID
  • Patient Summary
  • Patient Gender
  • Patient Age
  • Drug Products
  • Drug Reactions


Ixazomib is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Ixazomib is used to treat multiple myeloma (bone marrow cancer), in combination chemotherapy with lenalidomide and dexamethasone. This combination is usually given after at least one other cancer medicine has been tried without success. Ixazomib may also be used for purposes not listed in this medication guide.https://www.drugs.com/mtm/ixazomib.html